2m 2m 2m 2m 2m 2m 2m
Phibro Animal-A (PAHC)
NASDAQ
$32.87-$0.13 (-0.40%)
Price as of Jul 14, 2026 5:37 AM EDT- $695.3MMarket Cap
- 5.95%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Phibro Animal-A (PAHC)
$32.87-$0.13 (-0.40%)
PAHC | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $33.00 | ||
Change | +$0.93 (+2.90%) | ||
Open | $30.89 | ||
High | $33.08 | ||
Low | $30.64 | ||
Previous Close | $32.07 | ||
Volume | 498,170 | ||
30-Day Average Volume | 308,021 | ||
1-Week Change | -3.31% | ||
1-Month Change | 4.66% | ||
1-Year Change | 5.95% | ||
3-Year Change | 140.45% | ||
5-Year Change | 45.84% | ||
Fundamentals | |||
Shares Outstanding | 21.1M | ||
Total Assets | $1.4B | ||
Market Cap | $695.3M | ||
Enterprise Value | $1.4B | ||
Period: QTR TTM FY | |||
Revenue | $383.5M | ||
Net Income | $24.0M | ||
Free Cash Flow | $890,000.00 | ||
EBIT | $42.7M | ||
EBITDA | $55.2M | ||
Net Working Capital | $612.2M | ||
EPS | $0.59 | ||
Enterprise Value/EBITDA | 25 | ||
Enterprise Value/Revenue | 4 | ||
P/B | 2 | ||
P/E | 56 | ||
PEG | -5 | ||
Price/Free Cash Flow | 781 | ||
Price/Operating Cash Flow | 43 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 1.45% | ||
Trailing Annual Dividend Yield | 1.45% | ||
Ex-Dividend Date | 06/03/2026 | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Annual Dividend Yield